Sandrock Alfred's Form 4 filing
Voyager Therapeutics, Inc. (VYGR) · filed Feb 24, 2025
- Accession no.
- 0001104659-25-016520
- Filed
- Feb 24, 2025
- Trade date
- Feb 20-21, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $49.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandrock AlfredCIK 0001577061 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Common Stock | SSaleDisposed | −11,702 | $4.24 | −$49,616.48 | 296,816 | Direct | |
| Feb 21, 2025 | Common Stock | AGrant or awardAcquired | +145,000 | $0.00 | $0 | 441,816 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | Common Stock | AGrant or awardAcquired | +290,000 | $0.00 | $0 | 290,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.